About Our Business
NovaXS is a therapeutic startup focused on improving treatment efficacy through an advanced drug delivery platform and innovative CRISPR gene therapy nanoparticle delivery.
To build a needle-free, transformative, and interactive drug delivery platform and present to the market a world-leading and life-changing biological proteins that treat chronic diseases.
Meet the Team
NovaXS is founded out of UC Berkeley
QB3 Laboratory led by world-famous regenerative medicine expert Professor Irina Conboy and a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful business exits.
Harvard Medical School
Ph.D. candidate 6 medical devices inventor Economist Intelligence Unit healthcare leader
UChicago Booth Part-time MBA Serial Entrepreneur 20x previous exit NBA Celebrity Resources